Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-009465
Filing Date
2022-05-12
Accepted
2022-05-12 07:28:44
Documents
68
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vigl-20220331.htm   iXBRL 10-Q 2318498
2 EX-31.1 vigl-ex31_1.htm EX-31.1 22707
3 EX-31.2 vigl-ex31_2.htm EX-31.2 22638
4 EX-32.1 vigl-ex32_1.htm EX-32.1 14024
5 EX-32.2 vigl-ex32_2.htm EX-32.2 13973
  Complete submission text file 0000950170-22-009465.txt   7951277

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vigl-20220331_lab.xml EX-101.LAB 473303
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vigl-20220331_cal.xml EX-101.CAL 43070
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vigl-20220331_def.xml EX-101.DEF 279179
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vigl-20220331_pre.xml EX-101.PRE 400945
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vigl-20220331.xsd EX-101.SCH 62070
62 EXTRACTED XBRL INSTANCE DOCUMENT vigl-20220331_htm.xml XML 1188787
Mailing Address 400 TECHNOLOGY SQUARE 10TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 10TH FLOOR CAMBRIDGE MA 02139 857-254-4445
Vigil Neuroscience, Inc. (Filer) CIK: 0001827087 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41200 | Film No.: 22915718
SIC: 2836 Biological Products, (No Diagnostic Substances)